Remove 2025 Remove Drug Development Remove Process Chemistry
article thumbnail

Optimizing Protocols to Seamlessly Transfer Med. Chem. Synthesis to Process Development

Fierce BioTech

Synthesis to Process Development pesurya Wed, 05/21/2025 - 16:25 Thu, 07/10/2025 - 10:00 Resource Type Webinar Xiang Li Qixuan Lu The transition from drug discovery to process development presents significant challenges. Optimizing Protocols to Seamlessly Transfer Med.

article thumbnail

Empowering women in STEM: Navigating CMC regulatory affairs

Drug Target Review

Dr Lopa Bakrania brings over 18 years of experience in pharmaceutical process chemistry and CMC regulatory affairs. As Executive Director of CMC Regulatory Affairs at Biohaven , she leads efforts to develop innovative therapies from the clinic to market approval. She is the head of CMC regulatory affairs at Biohaven.

Science 59